Pediatrics

The FDA has set a PDUFA target action date of October 23, 2025, for the low-dose atropine formulation.

Inflammation and scarring are the primary obstacles with pirfenidone.

These tools help fill a gap that current technologies cannot achieve as effectively.

Children experienced sudden vision loss, visual field constriction, nyctalopia and dyschromatopsia following febrile illness.

The research team conducted a prospective study to assess any barriers to parental compliance with vision testing in preschoolers aged 3 to 6 years.

Zhaoke Ophthalmology Limited is responsible for developing and obtaining regulatory approval for NVK-002 in Greater China, South Korea, and the Southeast Asian territories.

Cost among other factors may deter patients from screening, especially in rural and low-resource settings.

The rationale was that commercial mydriatics administered during retinopathy of prematurity (ROP) screening have been associated with cardiorespiratory and gastrointestinal adverse events.

Researchers at the University of Colorado Anschutz Medical Campus found that characters with crossed or drifting eyes are more likely to play more minor roles in animated movies and be considered unintelligent or villainous. These depictions, the researchers say, can have harmful effects for children with strabismus by perpetuating stereotypes.

In the wake of a report by a group of researchers in China detailing the increasing prevalence of myopia worldwide, Daniel Cyr, MD, a pediatric ophthalmologist at Stony Brook Medicine, agreed with its assessment, telling Ophthalmology Times he is seeing an increase in pediatric myopia at his clinic in New York.

Research is needed to establish the best diagnostic and management strategies for increasingly common condition

The designations underscore the unmet need in Stargardt disease, a rare and serious pediatric disease for which no treatment exists.

NEI Initiative aims to boost awareness, standardize diagnosis, and improve care for children with CVI through multidisciplinary collaboration and emerging technologies.

Analysis highlights discrepancies between adult, pediatric cataract procedures.

FELIQS plans to conduct a Phase 1b/2 study of FLQ-101 (tROPhy-1 study) both in the US and Japan in the first quarter of 2025.

NEI Initiative aims to boost awareness, standardize diagnosis, and improve care for children with CVI through multidisciplinary collaboration and emerging technologies.

A study clarifies the relationship between postnatal weight gain and ROP development.

According to a presentation at the American Academy of Ophthalmology’s annual meeting in Chicago, a new study shows customized eyeglasses successfully addressed children’s complex eye needs.

A team of researchers at Arizona State University has developed tools to aid in the diagnosis of myopic maculopathy.

Coordinated by the International Agency for the Prevention of Blindness under the Love Your Eyes campaign banner, World Sight Day 2024 is putting children front and center in this year’s campaign.

Presented by the National Center for Children’s Vision and Eye Health at Prevent Blindness, the Bonnie Strickland Champion for Children’s Vision Award recognizes efforts by an individual or group of individuals, to improve public health approaches for children’s vision and eye health.

The report urges the US Department of Health and Human Services, in collaboration with departments of education at the state level, to take measures to ensure that children receive a vision screening before first grade and a comprehensive eye exam, when needed.

According to the organization, the map and report provide public, professionals and decisionmakers with data on children’s vision issues at the county and state level.

Prevent Blindness is planning a series of events and program partnerships leading up to World Sight Day on Oct. 10, 2024.

The day will be held on October 10. It is coordinated by the International Agency for the Prevention of Blindness under the “Love Your Eyes” campaign banner, and is putting children at the center of the campaign.

CN6 palsy from the COVID-19 virus is rare, and can occur in infants as young as 7 months.